Literature DB >> 11359693

Fumonisin toxicosis in swine: an overview of porcine pulmonary edema and current perspectives.

W M Haschek1, L A Gumprecht, G Smith, M E Tumbleson, P D Constable.   

Abstract

Fumonisin toxicosis in swine was named porcine pulmonary edema (PPE) after outbreaks of a fatal disease in pigs fed Fusarium verticillioides (F. moniliforme)-contaminated corn screenings from the 1989 corn crop in Iowa, Illinois, and Georgia. Pigs that died had severe pulmonary edema, which has not been identified in other species after exposure to fumonisins. The disease has been reproduced experimentally by feeding of naturally contaminated corn, F. verticillioides culture material, and by intravenous administration of fumonisin B1 (FB1). Hepatic lesions consisting of apoptosis, necrosis, and hepatocyte proliferation also are observed. As in other species, alterations in clinical pathology reflect hepatic injury as well as elevated serum cholesterol concentration. In chronic studies, esophageal plaques, hyperplastic hepatic nodules, and right ventricular hypertrophy were found. In pigs, as in other species, fumonisin alters sphingolipid biosynthesis, with the greatest alterations in sphingosine and sphinganine concentrations in kidney, liver, lung, and heart. Our recent studies on fumonisin toxicosis in pigs have focused on immune effects and the pathogenesis of pulmonary edema. The specific immune system was not affected; however, FB1 inhibited phagocytosis and sphingolipid biosynthesis in pulmonary macrophages. Fumonisin induced an accumulation of membranous material in pulmonary capillary endothelial cells; this change appears specific to this cell type and to swine. In short-term cardiovascular studies, fumonisin decreased left ventricular dP/dt(max) (an index of cardiac contractility), mean systemic arterial pressure, heart rate, and cardiac output, and increased mean pulmonary artery pressure and pulmonary artery wedge pressure. These changes are compatible with the inhibition of L-type calcium channels by increased sphingosine and/or sphinganine concentration. Therefore, fumonisin-induced pulmonary edema in swine appears to result from acute left-sided heart failure mediated by altered sphingolipid biosynthesis.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11359693      PMCID: PMC1240673          DOI: 10.1289/ehp.01109s2251

Source DB:  PubMed          Journal:  Environ Health Perspect        ISSN: 0091-6765            Impact factor:   9.031


  49 in total

1.  Ingestion of fumonisin B1-containing culture material decreases cardiac contractility and mechanical efficiency in swine.

Authors:  P D Constable; G W Smith; G E Rottinghaus; W M Haschek
Journal:  Toxicol Appl Pharmacol       Date:  2000-02-01       Impact factor: 4.219

2.  Species and organ specificity of fumonisin-induced endothelial alterations: potential role in porcine pulmonary edema.

Authors:  L A Gumprecht; G W Smith; P C Constable; W M Haschek
Journal:  Toxicology       Date:  2001-03-07       Impact factor: 4.221

3.  Pulmonary edema and hydrothorax in swine produced by fumonisin B1, a toxic metabolite of Fusarium moniliforme.

Authors:  L R Harrison; B M Colvin; J T Greene; L E Newman; J R Cole
Journal:  J Vet Diagn Invest       Date:  1990-07       Impact factor: 1.279

4.  Characterization of an epizootic of pulmonary edema in swine associated with fumonisin in corn screenings.

Authors:  G D Osweiler; P F Ross; T M Wilson; P E Nelson; S T Witte; T L Carson; L G Rice; H A Nelson
Journal:  J Vet Diagn Invest       Date:  1992-01       Impact factor: 1.279

5.  Sequence of cardiovascular changes leading to pulmonary edema in swine fed culture material containing fumonisin.

Authors:  G W Smith; P D Constable; M E Tumbleson; G E Rottinghaus; W M Haschek
Journal:  Am J Vet Res       Date:  1999-10       Impact factor: 1.156

6.  Purified fumonisin B(1) decreases cardiovascular function but does not alter pulmonary capillary permeability in swine.

Authors:  G W Smith; P D Constable; R M Eppley; M E Tumbleson; L A Gumprecht; W M Haschek-Hock
Journal:  Toxicol Sci       Date:  2000-07       Impact factor: 4.849

7.  Pulmonary clearance of blood-borne bacteria.

Authors:  S H Crocker; B D Lowery; D O Eddy; B L Wismar; W J Buesching; R N Obenauf
Journal:  Surg Gynecol Obstet       Date:  1981-12

8.  Inhibition of sphingolipid biosynthesis by fumonisins. Implications for diseases associated with Fusarium moniliforme.

Authors:  E Wang; W P Norred; C W Bacon; R T Riley; A H Merrill
Journal:  J Biol Chem       Date:  1991-08-05       Impact factor: 5.157

9.  A comparative study of the toxicity of Fusarium verticillioides (= F. moniliforme) to horses, primates, pigs, sheep and rats.

Authors:  N P Kriek; T S Kellerman; W F Marasas
Journal:  Onderstepoort J Vet Res       Date:  1981-06       Impact factor: 1.792

10.  Leukoencephalomalacia in a horse induced by fumonisin B1 isolated from Fusarium moniliforme.

Authors:  W F Marasas; T S Kellerman; W C Gelderblom; J A Coetzer; P G Thiel; J J van der Lugt
Journal:  Onderstepoort J Vet Res       Date:  1988-12       Impact factor: 1.792

View more
  33 in total

1.  Expanded genetic map of Gibberella moniliformis (Fusarium verticillioides).

Authors:  James E Jurgenson; Kurt A Zeller; John F Leslie
Journal:  Appl Environ Microbiol       Date:  2002-04       Impact factor: 4.792

2.  Optic neuropathy in a herd of beef cattle in Alberta associated with consumption of moldy corn.

Authors:  Lynne S Sandmeyer; Vladimir Vujanovic; Lyall Petrie; John R Campbell; Bianca S Bauer; Andrew L Allen; Bruce H Grahn
Journal:  Can Vet J       Date:  2015-03       Impact factor: 1.008

Review 3.  Recent advancements in the biosynthetic mechanisms for polyketide-derived mycotoxins.

Authors:  Justin Huffman; Ryan Gerber; Liangcheng Du
Journal:  Biopolymers       Date:  2010-09       Impact factor: 2.505

4.  Occurrence and fumonisin B2 producing potential of Aspergillus section Nigri in Brazil nuts.

Authors:  Larissa S Ferranti; Benedito Correa; Maria Helena P Fungaro; Beatriz T Iamanaka; Fernanda P Massi; Christopher B W Phippen; Jens C Frisvad; Marta H Taniwaki
Journal:  Mycotoxin Res       Date:  2016-11-05       Impact factor: 3.833

5.  Production of beauvericin, moniliformin, fusaproliferin, and fumonisins b(1), b(2), and b(3) by fifteen ex-type strains of fusarium species.

Authors:  Joseph Fotso; John F Leslie; J Scott Smith
Journal:  Appl Environ Microbiol       Date:  2002-10       Impact factor: 4.792

6.  Fusarium species (section Liseola) occurrence and natural incidence of beauvericin, fusaproliferin and fumonisins in maize hybrids harvested in Mexico.

Authors:  Waldina P Reyes-Velázquez; Rosa M Figueroa-Gómez; Mauricio Barberis; María Marta Reynoso; Federico G A Rojo; Sofía N Chulze; Adriana M Torres
Journal:  Mycotoxin Res       Date:  2011-05-17       Impact factor: 3.833

7.  Co-occurrence of five Fusarium toxins in corn-Dried Distiller's Grains with Solubles in Thailand and comparison of ELISA and LC-MS/MS for fumonisin analysis.

Authors:  Natthasit Tansakul; Prakorn Jala; Sudtisa Laopiem; Prapeuk Tangmunkhong; Sasithorn Limsuwan
Journal:  Mycotoxin Res       Date:  2013-07-28       Impact factor: 3.833

8.  Mycotoxin fumonisin B1 increases intestinal colonization by pathogenic Escherichia coli in pigs.

Authors:  Isabelle P Oswald; Clarisse Desautels; Joëlle Laffitte; Sylvie Fournout; Sylvie Y Peres; Marielle Odin; Pierrette Le Bars; Joseph Le Bars; John M Fairbrother
Journal:  Appl Environ Microbiol       Date:  2003-10       Impact factor: 4.792

9.  The food contaminant fumonisin B(1) reduces the maturation of porcine CD11R1(+) intestinal antigen presenting cells and antigen-specific immune responses, leading to a prolonged intestinal ETEC infection.

Authors:  Bert Devriendt; Me'lanie Gallois; Frank Verdonck; Yann Wache; Diane Bimczok; Isabelle P Oswald; Bruno M Goddeeris; Eric Cox
Journal:  Vet Res       Date:  2009-04-24       Impact factor: 3.683

10.  Effect of low dose of fumonisins on pig health: immune status, intestinal microbiota and sensitivity to Salmonella.

Authors:  Christine Burel; Mael Tanguy; Philippe Guerre; Eric Boilletot; Roland Cariolet; Marilyne Queguiner; Gilbert Postollec; Philippe Pinton; Gilles Salvat; Isabelle P Oswald; Philippe Fravalo
Journal:  Toxins (Basel)       Date:  2013-04-23       Impact factor: 4.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.